Sartorius Stedim Biotech S.A. (EPA:DIM)
174.70
+3.50 (2.04%)
May 28, 2026, 5:35 PM CET
Sartorius Stedim Biotech Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Sartorius Stedim Biotech stock has a consensus rating of "Buy" and an average price target of €232.43. The average 1-year stock price forecast is 33.05% higher than the current stock price, while the lowest is €210.00 (+20.21%) and the highest is €262.00 (+49.97%).
Price Target: €232.43 (+33.05%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sartorius Stedim Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 7 | 7 | 7 |
| Buy | 5 | 4 | 4 | 6 | 6 | 6 |
| Hold | 2 | 5 | 5 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | +20.21% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains €220.00 | Buy | Maintains | €220.00 | +25.93% | Apr 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +48.83% | Apr 23, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €214.00 | Buy | Maintains | €214.00 | +22.50% | Apr 23, 2026 |
| UBS | UBS | Hold Maintains €220.00 | Hold | Maintains | €220.00 | +25.93% | Apr 17, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.